![EP 78: Your Guide to Lipoprotein(a) with Dr. Salim S Virani](https://assets.radcliffecardiology.com/s3fs-public/podcast/2024-03/3000x3000_Parallax_Episode_Artwork_EP78.png?VersionId=OftMxrz6Le1y7CLLgGv8NMYrQvzerrdK)
This week’s Parallax episode is focusing on the latest science and questions surrounding one of the conundrums of cardiovascular science: Lipoprotein(a).
Dr. Ankur Kalra invites Dr Salim S Virani to help simplify the concept of Lp(a) with answering key questions about its measurement and its place in practice and prevention.
Dr Virani is a Professor at Baylor College of Medicine, Director of the Cardiovascular Disease Fellowship Program and Vice Provost of Research at Aga Khan University from early next year.
Lp(a) was first described in 1963. Since then, many epidemiologic studies have noted association of high Lp(a) levels with elevated risk of cardiovascular disease, however, the role of this particle remained a conundrum (Kamstrup, 2017). New data from the development of novel drugs are offering strong evidence on the causality between Lp(a) and ASCVD and AVS (Kronenber et al. 2022).
Dr Virani, one of the authors of the new European Atherosclerosis Society consensus statement on Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis, summarises the key concepts, shares his advice on clinical practice and talks about emerging therapies.
What is Lp(a) and what are the main associations? In what patient population should we lower LP(a)? What do you tell patients about Lp(a) testing and how easy it is to get it tested?
Questions and comments can be sent to “podcast@radcliffe-group.com” and may be answered by Ankur in the next episode.
Guest: @virani_md, host: @AnkurKalraMD and produced by: @RadcliffeCARDIO.
![Guest Episode: Exploring Art & Advancement Within Medicine](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2022-10/1920x1080_Web_Artwork_EP79_InternalMedicine_GuestEp.png?VersionId=525ZnCmWVbVDwJWYG.hfN3sPd_KS0ML0&itok=GWUYT15m)
Exploring Art & Advancement Within Medicine - A Conversation with an Interventional Cardiologist.
![EP 117: Transforming Cardiac Surgery Recovery: Evidence-Based Insights with Dr Gerdisch](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-08/DELV-23187_IND_Parallax_EP117_Gerdisch_Web_1920x1080.jpg?VersionId=10jQcg6sZufXOZ_V2.eXBcL2gcTGQckL&itok=QUtGQF0H)
Dr Gerdisch shares insights into his research on rigid sternal fixation and enhanced recovery protocols, which have shown promising results in postoperative pain management and patient recovery.
![EP 116: Navigating the Realities of Guideline Directed Medical Therapy with Dr Chahoud and Dr Israel](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-07/DELV-17584_ZOLL_Parallax_3_Web_1920x1080_0.jpg?VersionId=7AsAfHb6JltTsIeGvFIL8PjSD_bJZQC7&itok=dAPVGO1r)
![EP 115: Navigating Cultures and Cardiology: Dr Janarthanan Sathananthan's Global Journey](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-07/DELV-22085_IND_Parallax_EP116_Sathananthan_Web_1920x1080.jpg?VersionId=X7UeGqRVZ0MB.gLJ_K0aoLflMIJqb8X.&itok=QOEUH6cW)
![The Leap Year Gene with Shelley Wood, Bestselling Author & Editor-in-Chief of TCTmd](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-06/DELV-21301_Parallax_EP114_Wood_Web_1920x1080.jpg?VersionId=o3p3VftF1kaRvWNWKzolgCRXyALPXFHt&itok=H2D2X7SD)
![EP 113: Your Guide to Radiation Hygiene: Insights from Manufacturer and Users](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-06/DELV-21795_Parallax_EP113_Breininger_Radtke_Web_1920x1080.jpg?VersionId=3d524UUeTRRuHi6Y8NqMN5n1WUksM6HI&itok=Eh3lMH-C)
![EP 112: Just One Heart: Burnout, Positive Mindset & Leadership with Dr Fisher](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-05/DELV-21579_Parallax_EP112_Fisher_Web_1920x1080.jpg?VersionId=NH6WDl3W2YJSM8.eRkQN4vq5MY2xbfEd&itok=tVbLnj0V)
![EP 111: ACC 24 in Review With Dr Vallabhajosyula: 5 Trials That Will Change Your Practice](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-04/DELV-21011_Parallax_EP111_Vallabhajosyula_Web_1920x1080.jpg?VersionId=ZOcxXpbfxpQgrVCl9j7I92zCplTgt1mZ&itok=LmOEuJkd)
![EP 110: Cultivating Leadership, Civic Duty & the Presidential Leadership Programme with Dr Sinha](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-04/DELV-20782_IND_Parallax_Sinha_Web_1920x1080-2.png?VersionId=o5_ez0NqChSi.6qI0.I0LGPQ4LmwK.Ac&itok=jmdoA2eD)
![EP 109: Navigating Volume Status in Heart Failure Patients with Dr Andrew Darlington](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-03/DELV-17583_ZOLL_Parallax_2_Web_1920x1080.jpg?VersionId=bavAruPc_yuREgwZwQomlSmR8bzSje6U&itok=ybL6yurd)
Together, Dr Kalra and Dr Darlington delve into the significance of assessing volume status in patients with heart failure, highlighting its continued relevance in 2024, including the availability of new diagnostic tools, including the Heart Failure Management System (HFMS).
This series is supported by ZOLL and is intended for Health Care Professionals.
![EP 108: Song of Our Scars: Authorship & Medicine with Senior Advisor for FDA, Dr Warraich](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/DELV-19380_IND_Parallax_EP108_Warraich_Web_1920x1080.jpg?VersionId=HPs.636T_kpikJm7DK8VEDs5f0aphHbL&itok=Nh_OhD_E)
![High-Sensitivity Cardiac Troponin ACS](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/Parallax-Podcast-w-Athena-%20Poppas_0.png?VersionId=uAw7s0xUwfjE1_1xcLbM7odh7YHQJw7K&itok=pSrlvyyg)
Chest pain is one of the most common reasons for an emergency room visit in the US, with almost 6 million ER visits annually, yet there is no consensus on how to compare the results from various hscTn assays. Tune in to hear Santiago outline the advantages and limitations of using hscTn as a standard biomarket to evaluate patients with suspected ACS in the ER.
Hosted by @AnkurKalraMD. Produced by @RadcliffeCardiology.
![01: Conduction Abnormalities After TAVR/TAVI With Chad Kliger](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-03/Parallax_01_1200x628.jpg?VersionId=8YtGXyCvpISHGUAWuUfXgEArl7M4TInv&itok=fTCIJSke)